CYAND | tickerfilter.com

Fundamental analysis

54%

Profitability 50%

Dept financing 50%

Liquidity 7%

Performance 70%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-17.14%

1 Month

-32.56%

3 Months

-33.33%

6 Months

-16.67%

1 Year

-17.14%

2 Year

-17.14%

Key data

Stock price

$0.29

P/E Ratio

0.00

DAY RANGE

$0.29 - $0.29

EPS

-$0.29

52 WEEK RANGE

$0.21 - $0.57

52 WEEK CHANGE

-$17.19

MARKET CAP

2.200 M

YIELD

N/A

SHARES OUTSTANDING

7.392 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

N/A

AVERAGE 10 VOLUME

$6,046

AVERAGE 30 VOLUME

$3,314

Company detail

CEO: Matthew Custer
Region: US
Website: cyanotech.com
Employees: 100
IPO year: 1993

Issue type:
Market: OTCM
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, and Hawaiian Spirulina Pacifica. The company sells its products as packaged consumer products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors.

CYAND - CYANOTECH CORP